Table 4.
Log2 fold changes (FC) and false discovery rates (FDR) of differentially expressed MHC and other immune response-related genes in the challenged-only group compared to the other groups.
| Gene name | Challenged-only group compared to: | |||||
|---|---|---|---|---|---|---|
| Negative control | Vaccinated-and-challenged | Vaccinated-only | ||||
| FC | FDR | FC | FDR | FC | FDR | |
| MHC antigen-related genes | ||||||
| Major histocompatibility complex, class II, DM alpha | 4.083 | 4.46E-05 | 2.507 | 1.94E-03 | 3.402 | 1.48E-04 |
| Major histocompatibility complex class I antigen BF2 | 2.605 | 6.78E-04 | 2.298 | 3.10E-03 | 2.6 | 7.01E-04 |
| Major histocompatibility complex, class II, DM beta 2 | 4.015 | 2.50E-04 | 2.842 | 3.51E-03 | 3.087 | 1.40E-03 |
| Major histocompatibility complex class II beta chain BLB2 | 2.824 | 8.01E-04 | 2.591 | 2.03E-03 | ||
| Major histocompatibility complex class II beta chain BLB1 | 3.544 | 3.12E-03 | 3.319 | 5.93E-03 | ||
| Major histocompatibility complex, class II, DM beta 1 | 5.857 | 2.08E-04 | 3.321 | 4.18E-03 | ||
| Major histocompatibility complex, class I, A6 | 2.183 | 1.25E-03 | ||||
| Immunoglobulin-related genes | ||||||
| Fc receptor-like protein 3-like | 4.575 | 4.10E-04 | 4.637 | 6.61E-04 | 6.047 | 2.07E-04 |
| V-set and immunoglobulin domain containing 4 | 2.717 | 3.01E-03 | 2.551 | 7.70E-03 | ||
| Immunoglobulin superfamily member 1-like | 6 | 1.37E-03 | 4.617 | 6.14E-03 | ||
| Immunoglobulin superfamily member 1 | 3.634 | 4.22E-03 | ||||
| Osteoclast-associated immunoglobulin-like receptor-like | 3.68 | 6.47E-03 | ||||
| Osteoclast-associated immunoglobulin-like receptor | 3.719 | 8.74E-03 | ||||
| Fc fragment of IgE receptor Ig | 4.237 | 8.44E-03 | ||||
| Immunoglobulin-like receptor CHIR-B3 | 3.568 | 9.53E-03 | ||||
| Toll-like receptors | ||||||
| Toll-like receptor 7 | 4.904 | 1.06E-03 | 4.306 | 3.40E-03 | 4.463 | 1.93E-03 |
| Toll-like receptor 2 family member B | 5.489 | 2.59E-03 | 5.295 | 4.82E-03 | 4.56 | 6.14E-03 |
| Toll-like receptor 1 family member A | 3.406 | 3.42E-03 | 3.597 | 4.83E-03 | 5.117 | 7.89E-04 |
| Toll-like receptor 5 | −2.747 | 3.54E-03 | ||||
| Complement-related genes | ||||||
| Complement C3a receptor 1 | 3.713 | 6.51E-04 | 4.005 | 9.40E-04 | 3.136 | 2.33E-03 |
| Complement C1s | 2.761 | 8.30E-04 | 2.913 | 8.11E-04 | 2.806 | 8.26E-04 |
| Complement C1q A chain | 3.028 | 1.53E-03 | 2.547 | 8.67E-03 | 2.761 | 3.83E-03 |
| Complement component 3 | 1.869 | 4.94E-03 | 2.063 | 2.06E-03 | 2.566 | 1.61E-04 |
| Complement 4 | 2.554 | 5.74E-03 | 2.555 | 8.69E-03 | 2.578 | 6.80E-03 |
| Complement C1q C chain | 3.131 | 2.14E-03 | 2.624 | 9.25E-03 | ||
| Complement C1q B chain | 3.52 | 3.27E-03 | ||||
| Complement C1q binding protein | 1.755 | 1.23E-03 | ||||
| Complement component 4 | 2.098 | 8.14E-03 | ||||
| Complement C7 | 3.353 | 9.07E-03 | ||||
A false discovery rate (FDR) of < 0.01 was considered significant.